Inhibitory growth evaluation and apoptosis induction in MCF-7 cancer cells by new 5-aryl-2-butylthio-1,3,4-oxadiazole derivatives
- 226 Downloads
Cancer has become one of the global health issues and it is the life-threatening disease characterized by unrestrained growth of cells. Despite various advances being adopted by chemotherapeutic management, the use of the current anticancer drugs such as Doxorubicin, Asparginase, Methotrexate, Vincristine remains limited due to high toxicity, side effects and developing drug resistance. Apoptosis is a crucial cellular process and improper regulation of apoptotic signaling pathways may lead to cancer formation. Subsequently, the synthesis of effective chemotherapeutic agents that can induce apoptosis in tumor cell has emerged as a significant approach in cancer drug discovery.
The goal of this work is to develop a potential antitumor agent exerting significant inhibitory effects on cancer cell and low cytotoxicity, for which we focused on the structural features of 1,3,4-oxadiazoles as it a privileged scaffold in modern medicinal chemistry and have the ability to inhibit growth factors, enzymes and kinases potentially involved in the attainment of cellular immortality and carcinogenesis.
In vitro MTT screening assay showed the compound 5-aminophenyl-2-butylthio-1,3,4-oxadiazole (5e) showing the highest inhibitory effect against MCF-7 cancer cell with IC50 value 10.05 ± 1.08 µM while it is much safer and less toxic on normal cell line (HEK-293). The dose-dependent treatment of MCF-7 cells with 5e resulted in inhibition of cell migration in the wound healing assay. The flow-cytometry analysis showed the cells arrested in G0/G1 phase of the cell cycle. Compound 5e induced apoptosis of MCF-7 cells was characterized using DAPI staining and Annexin V-PE/7-AAD dual binding assay. Reduction of NBT by compound 5e showed a reduced generation of ROS. Western blotting studies showed high activation of apoptotic protein Caspase3 and decrease in expression of anti-apoptotic protein BCL-2.
Based on the results of in vitro studies, it could be concluded that compound 5e showed a significant inhibitory growth effect on MCF-7 cells and have the potential to be developed as lead molecule and further structural modifications may result in promising new anticancer agents.
Keywords1,3,4-Oxadiazole derivatives Apoptosis Inhibition growth assay Drug-like properties
This research work had supported by UGC (F no-43-172/2014 (SR). Author Rashmin Khanam is grateful to UGC for providing NON-Net fellowship for financial support and Dr. Syed Shahabuddin for great help.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
Research involving human or animal participants
This article does not contain any studies with human participants or animals performed by any of the authors.
- 1.Senwar KR, Reddy TS, Thummuri D, Sharma P, Naidu VG, Srinivasulu G, Shankaraiah N (2016) Design, synthesis and apoptosis inducing effect of novel (Z)-3-(3′-methoxy-4′-(2-amino-2-oxoethoxy)-benzylidene)indolin-2-ones as potential antitumour agents. Eur J Med Chem 118:34–46CrossRefPubMedGoogle Scholar
- 4.Sharma P, Thummuri D, Reddy TS, Senwar KR, Naidu VG, Srinivasulu G, Bharghava SK, Shankaraiah N (2016) New (E)-1-alkyl-1H-benzo[d]imidazol-2-yl)methylene)indolin-2-ones: synthesis, in vitro cytotoxicity evaluation and apoptosis inducing studies. Eur J Med Chem 122:584–600CrossRefPubMedGoogle Scholar
- 9.Zhang F, Wang XL, Shi J, Wang SF, Yin Y, Yang YS, Zhang WM, Zhu HL (2014) Synthesis, molecular modeling and biological evaluation of N-benzylidene-2-((5-(pyridin-4-yl)-1,3,4-oxadiazol-2-yl)thio)acetohydrazide derivatives as potential anticancer agents. Bioorg Med Chem 22:468–477CrossRefPubMedGoogle Scholar
- 10.Valente S, Trisciuoglio D, De Luca T, Nebbioso A, Labella D, Lenoci A, Bigogno C, Dondio G, Miceli M, Brosch G, Del Bufalo D, Altucci L, Mai A (2014) 1,3,4-Oxadiazole-containing histone deacetylase inhibitors: anticancer activities in cancer cells. J Med Chem 57:6259–6265CrossRefPubMedGoogle Scholar
- 14.Cai ZW, Wei D, Borzilleri RM, Qian L, Kamath A, Mortillo S, Wautlet B, Henley BJ, Jeyaseelan R Sr, Tokarski J, Hunt JT, Bhide RS, Fargnoli J, Lombardo LJ (2008) Synthesis, SAR, and evaluation of 4-[2,4-difluoro-5-(cyclopropylcarbamoyl)phenylamino]pyrrolo[2,1-f][1, 2, 4]triazine-based VEGFR-2 kinase inhibitors. Bioorg Med Chem Lett 18:1354–1358CrossRefPubMedGoogle Scholar
- 16.Shahzad SA, Yar M, Bajda M, Jadoon B, Khan ZA, Naqvi SA, Shaikh AJ, Hayat K, Mahmmod A, Mahmood N, Filipek S (2014) Synthesis and biological evaluation of novel oxadiazole derivatives: a new class of thymidine phosphorylase inhibitors as potential anti-tumor agents. Bioorg Med Chem 22:1008–1015CrossRefPubMedGoogle Scholar
- 18.Agelis G, Resvani A, Koukoulitsa C, Tumova T, Slaninova J, Kalavrizioti D, Spyridaki K, Afantitis A, Melagraki G, Siafaka A, Gkini E, Megariotis G, Grdadolnik SG, Papadopoulos MG, Vlahakos D, Maragoudakis M, Liapakis G, Mavromoustakos T, Matsoukas J (2013) Rational design, efficient syntheses and biological evaluation of N,N′-symmetrically bis-substituted butylimidazole analogs as a new class of potent Angiotensin II receptor blockers. Eur J Med Chem 62:352–370CrossRefPubMedGoogle Scholar
- 30.Praveen Kumar C, Reddy TS, Mainkar PS, Bansal V, Shukla R, Chandrasekhar S, Hugel HM (2016) Synthesis and biological evaluation of 5,10-dihydro-11H-dibenzo[b, e][1, 4]diazepin-11-one structural derivatives as anti-cancer and apoptosis inducing agents. Eur J Med Chem 108:674–686CrossRefPubMedGoogle Scholar
- 33.Syarifah MS (2011) Potential anticancer compound from Cerbera odollam. J Tropic For Sci 23:89–96Google Scholar
- 38.Thummuri D, Jeengar MK, Shrivastava S, Areti A, Yerra VG, Yamjala S, Komirishetty P, Naidu VG, Kumar A, Sistla R (2014) Boswellia ovalifoliolata abrogates ROS mediated NF-kappaB activation, causes apoptosis and chemosensitization in Triple Negative Breast Cancer cells. Environ Toxicol Pharmacol 38:58–70CrossRefPubMedGoogle Scholar